Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of interferon-alpha production (GO:0032727) | 4.35659881 |
2 | regulation of interferon-alpha production (GO:0032647) | 4.15110789 |
3 | complement activation, alternative pathway (GO:0006957) | 3.98843455 |
4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.88883701 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87248593 |
6 | negative regulation of cell killing (GO:0031342) | 3.87248593 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 3.80621440 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.79316768 |
9 | L-phenylalanine catabolic process (GO:0006559) | 3.79316768 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.79218697 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.79218697 |
12 | indole-containing compound catabolic process (GO:0042436) | 3.79056480 |
13 | indolalkylamine catabolic process (GO:0046218) | 3.79056480 |
14 | tryptophan catabolic process (GO:0006569) | 3.79056480 |
15 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.73673604 |
16 | protein carboxylation (GO:0018214) | 3.72410108 |
17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.72410108 |
18 | regulation of protein activation cascade (GO:2000257) | 3.66137616 |
19 | negative regulation of fibrinolysis (GO:0051918) | 3.65185899 |
20 | response to peptidoglycan (GO:0032494) | 3.59681405 |
21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.57653772 |
22 | L-phenylalanine metabolic process (GO:0006558) | 3.57653772 |
23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.57107830 |
24 | kynurenine metabolic process (GO:0070189) | 3.56106687 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 3.54117995 |
26 | tryptophan metabolic process (GO:0006568) | 3.52236316 |
27 | regulation of complement activation (GO:0030449) | 3.44728406 |
28 | plasma lipoprotein particle clearance (GO:0034381) | 3.41137874 |
29 | urea metabolic process (GO:0019627) | 3.40322141 |
30 | urea cycle (GO:0000050) | 3.40322141 |
31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.36560496 |
32 | regulation of fibrinolysis (GO:0051917) | 3.36459170 |
33 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28317225 |
34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.27891968 |
35 | high-density lipoprotein particle remodeling (GO:0034375) | 3.20752123 |
36 | neutrophil activation involved in immune response (GO:0002283) | 3.16652186 |
37 | phospholipid efflux (GO:0033700) | 3.14635869 |
38 | cellular extravasation (GO:0045123) | 3.13821448 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 3.13222249 |
40 | protein localization to endosome (GO:0036010) | 3.11477788 |
41 | bile acid biosynthetic process (GO:0006699) | 3.11285940 |
42 | acute-phase response (GO:0006953) | 3.08089417 |
43 | negative regulation of interleukin-12 production (GO:0032695) | 3.04489132 |
44 | low-density lipoprotein particle clearance (GO:0034383) | 3.03384324 |
45 | nitrogen cycle metabolic process (GO:0071941) | 3.02227926 |
46 | regulation of RIG-I signaling pathway (GO:0039535) | 2.99280695 |
47 | fibrinolysis (GO:0042730) | 2.93845141 |
48 | cysteine metabolic process (GO:0006534) | 2.92662315 |
49 | regulation of cholesterol storage (GO:0010885) | 2.92484883 |
50 | negative regulation of bone mineralization (GO:0030502) | 2.91225389 |
51 | negative regulation of cholesterol transport (GO:0032375) | 2.90727706 |
52 | negative regulation of sterol transport (GO:0032372) | 2.90727706 |
53 | reverse cholesterol transport (GO:0043691) | 2.89813053 |
54 | macrophage activation involved in immune response (GO:0002281) | 2.88386743 |
55 | glyoxylate metabolic process (GO:0046487) | 2.87089438 |
56 | positive regulation of blood coagulation (GO:0030194) | 2.85500405 |
57 | positive regulation of hemostasis (GO:1900048) | 2.85500405 |
58 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84720947 |
59 | plasma lipoprotein particle assembly (GO:0034377) | 2.84647171 |
60 | phospholipid homeostasis (GO:0055091) | 2.82153357 |
61 | positive regulation of coagulation (GO:0050820) | 2.81508050 |
62 | positive regulation of lipid catabolic process (GO:0050996) | 2.80396668 |
63 | response to muramyl dipeptide (GO:0032495) | 2.79922881 |
64 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79784462 |
65 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79784462 |
66 | modulation by symbiont of host immune response (GO:0052553) | 2.79784462 |
67 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79784462 |
68 | modulation by symbiont of host defense response (GO:0052031) | 2.79784462 |
69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79784462 |
70 | detection of other organism (GO:0098543) | 2.79264513 |
71 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.78814781 |
72 | positive regulation of interferon-beta production (GO:0032728) | 2.77974320 |
73 | detection of molecule of bacterial origin (GO:0032490) | 2.77414070 |
74 | regulation of cholesterol homeostasis (GO:2000188) | 2.76291544 |
75 | protein-lipid complex remodeling (GO:0034368) | 2.75124165 |
76 | macromolecular complex remodeling (GO:0034367) | 2.75124165 |
77 | plasma lipoprotein particle remodeling (GO:0034369) | 2.75124165 |
78 | regulation of cholesterol esterification (GO:0010872) | 2.73658051 |
79 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.72357035 |
80 | regulation of humoral immune response (GO:0002920) | 2.72020369 |
81 | leukocyte aggregation (GO:0070486) | 2.71933154 |
82 | sulfur amino acid catabolic process (GO:0000098) | 2.71619341 |
83 | protein-lipid complex assembly (GO:0065005) | 2.70689017 |
84 | cholesterol efflux (GO:0033344) | 2.70329134 |
85 | protein activation cascade (GO:0072376) | 2.70155578 |
86 | acylglycerol homeostasis (GO:0055090) | 2.67552970 |
87 | triglyceride homeostasis (GO:0070328) | 2.67552970 |
88 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.67149947 |
89 | complement activation (GO:0006956) | 2.66295523 |
90 | positive regulation of humoral immune response (GO:0002922) | 2.66143670 |
91 | mannose metabolic process (GO:0006013) | 2.65928215 |
92 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.65886120 |
93 | iron ion import (GO:0097286) | 2.63878602 |
94 | negative regulation of lipase activity (GO:0060192) | 2.63360203 |
95 | complement activation, classical pathway (GO:0006958) | 2.62710782 |
96 | germinal center formation (GO:0002467) | 2.61843653 |
97 | bile acid metabolic process (GO:0008206) | 2.60140594 |
98 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.59936583 |
99 | negative regulation of biomineral tissue development (GO:0070168) | 2.59836288 |
100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.58212373 |
101 | cellular response to virus (GO:0098586) | 2.58077242 |
102 | detection of external biotic stimulus (GO:0098581) | 2.57993337 |
103 | detection of bacterium (GO:0016045) | 2.57871132 |
104 | blood coagulation, intrinsic pathway (GO:0007597) | 2.57766693 |
105 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.57217710 |
106 | neutrophil activation (GO:0042119) | 2.56483466 |
107 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54995676 |
108 | positive thymic T cell selection (GO:0045059) | 2.54173241 |
109 | positive regulation of bone resorption (GO:0045780) | 2.54103730 |
110 | positive regulation of bone remodeling (GO:0046852) | 2.54103730 |
111 | granulocyte activation (GO:0036230) | 2.54072085 |
112 | regulation of leukocyte degranulation (GO:0043300) | 2.54050844 |
113 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.53069219 |
114 | aromatic amino acid family metabolic process (GO:0009072) | 2.51905808 |
115 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.50821946 |
116 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.50740819 |
117 | response to laminar fluid shear stress (GO:0034616) | 2.50181483 |
118 | regulation of mast cell degranulation (GO:0043304) | 2.49434890 |
119 | cellular response to ethanol (GO:0071361) | 2.48702122 |
120 | indolalkylamine metabolic process (GO:0006586) | 2.48517957 |
121 | amino-acid betaine metabolic process (GO:0006577) | 2.48192661 |
122 | homocysteine metabolic process (GO:0050667) | 2.44965727 |
123 | negative regulation of lipid storage (GO:0010888) | 2.44752457 |
124 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43919286 |
125 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.42528175 |
126 | positive regulation of lipid storage (GO:0010884) | 2.41867450 |
127 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.41704205 |
128 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.41704205 |
129 | response to type I interferon (GO:0034340) | 2.41462522 |
130 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.41459684 |
131 | regulation of necroptotic process (GO:0060544) | 2.41222294 |
132 | negative thymic T cell selection (GO:0045060) | 2.37628833 |
133 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.37258531 |
134 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.37219068 |
135 | pinocytosis (GO:0006907) | 2.36524026 |
136 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.33919443 |
137 | regulation of T cell tolerance induction (GO:0002664) | 2.32794825 |
138 | negative T cell selection (GO:0043383) | 2.30694214 |
139 | cellular response to type I interferon (GO:0071357) | 2.30619677 |
140 | type I interferon signaling pathway (GO:0060337) | 2.30619677 |
141 | T cell migration (GO:0072678) | 2.27952763 |
142 | response to thyroid hormone (GO:0097066) | 2.27004594 |
143 | negative regulation of T cell mediated immunity (GO:0002710) | 2.24984785 |
144 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.23953417 |
145 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.23254077 |
146 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.22760839 |
147 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.22747453 |
148 | macrophage activation (GO:0042116) | 2.22521850 |
149 | thymic T cell selection (GO:0045061) | 2.21903144 |
150 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.21876431 |
151 | detection of biotic stimulus (GO:0009595) | 2.20563998 |
152 | negative regulation of innate immune response (GO:0045824) | 2.19703635 |
153 | T cell selection (GO:0045058) | 2.17997111 |
154 | positive T cell selection (GO:0043368) | 2.17486855 |
155 | tolerance induction (GO:0002507) | 2.17418762 |
156 | response to interleukin-15 (GO:0070672) | 2.17015740 |
157 | positive regulation of receptor recycling (GO:0001921) | 2.16693281 |
158 | interferon-gamma secretion (GO:0072643) | 2.15932033 |
159 | regulation of tolerance induction (GO:0002643) | 2.15923906 |
160 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.15439499 |
161 | response to host (GO:0075136) | 2.15439499 |
162 | response to host defenses (GO:0052200) | 2.15439499 |
163 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.15340098 |
164 | positive regulation of cholesterol efflux (GO:0010875) | 2.14576338 |
165 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.13792680 |
166 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.13020764 |
167 | hepatocyte apoptotic process (GO:0097284) | 2.12103971 |
168 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.11931625 |
169 | positive regulation of type 2 immune response (GO:0002830) | 2.11662050 |
170 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.11291643 |
171 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.10642223 |
172 | positive regulation of extracellular matrix organization (GO:1903055) | 2.10496719 |
173 | defense response to protozoan (GO:0042832) | 2.10101173 |
174 | immunoglobulin mediated immune response (GO:0016064) | 2.08985199 |
175 | myeloid cell activation involved in immune response (GO:0002275) | 2.08270224 |
176 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.08053735 |
177 | NIK/NF-kappaB signaling (GO:0038061) | 2.06792595 |
178 | regulation of response to interferon-gamma (GO:0060330) | 2.06293421 |
179 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.06191648 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.19512700 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.25634607 |
3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.46259964 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.32736354 |
5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.89278688 |
6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.65546215 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.40820955 |
8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.23531666 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22301576 |
10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.21428650 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.92208528 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90315504 |
13 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.81193184 |
14 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56213340 |
15 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.48807658 |
16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.46445852 |
17 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44980208 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.43841703 |
19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.36430709 |
20 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33318678 |
21 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32050063 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.31396922 |
23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29361859 |
24 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.16858630 |
25 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.14706764 |
26 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08218019 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07603968 |
28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02327499 |
29 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00883221 |
30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99898284 |
31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91229403 |
32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89597302 |
33 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.79370552 |
34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75071840 |
35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66221095 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63416775 |
37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62321247 |
38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59871857 |
39 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58630277 |
40 | * MAF_26560356_Chip-Seq_TH1_Human | 1.54105073 |
41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47351534 |
42 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.47141320 |
43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.46429104 |
44 | MYC_22102868_ChIP-Seq_BL_Human | 1.46020621 |
45 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44668982 |
46 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42033511 |
47 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.41332918 |
48 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.40737813 |
49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40132111 |
50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39915613 |
51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39822737 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39237414 |
53 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.38430285 |
54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32636311 |
55 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32459144 |
56 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31384043 |
57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30465203 |
58 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30367502 |
59 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28600213 |
60 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28529639 |
61 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25427890 |
62 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.25194461 |
63 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25106662 |
64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24892320 |
65 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22393719 |
66 | * MYB_26560356_Chip-Seq_TH2_Human | 1.21339518 |
67 | * MAF_26560356_Chip-Seq_TH2_Human | 1.20420282 |
68 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20395041 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20388255 |
70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.19810683 |
71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.19810683 |
72 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18870164 |
73 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.18723380 |
74 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18123345 |
75 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18056542 |
76 | * MYB_26560356_Chip-Seq_TH1_Human | 1.17019360 |
77 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.16777428 |
78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16319499 |
79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15506655 |
80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15211690 |
81 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14105826 |
82 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.09823914 |
83 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07529264 |
84 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07090951 |
85 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06698826 |
86 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.05492412 |
87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04412342 |
88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04340197 |
89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03337596 |
90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02936669 |
91 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02122953 |
92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01155158 |
93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00009854 |
94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95435607 |
95 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.93916603 |
96 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93349919 |
97 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92471766 |
98 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92329861 |
99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90014275 |
100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.88012323 |
101 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87563351 |
102 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87005778 |
103 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85953443 |
104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85015487 |
105 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85006040 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84846401 |
107 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83224267 |
108 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.83171826 |
109 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82947640 |
110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82410688 |
111 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.82126738 |
112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81740971 |
113 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81217514 |
114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80742916 |
115 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79328407 |
116 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.79217254 |
117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78552577 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.46938138 |
2 | MP0005360_urolithiasis | 3.86873587 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.14352665 |
4 | MP0005451_abnormal_body_composition | 3.10257712 |
5 | MP0005365_abnormal_bile_salt | 3.04133579 |
6 | MP0009840_abnormal_foam_cell | 2.62149780 |
7 | MP0003436_decreased_susceptibility_to | 2.61470251 |
8 | MP0003303_peritoneal_inflammation | 2.47012812 |
9 | MP0001835_abnormal_antigen_presentation | 2.42973529 |
10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34823328 |
11 | MP0003724_increased_susceptibility_to | 2.34415616 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.29616748 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.27973187 |
14 | MP0005083_abnormal_biliary_tract | 2.23486686 |
15 | MP0009785_altered_susceptibility_to | 2.22225342 |
16 | MP0003252_abnormal_bile_duct | 2.18303805 |
17 | MP0010329_abnormal_lipoprotein_level | 2.14279740 |
18 | MP0000685_abnormal_immune_system | 2.03729967 |
19 | MP0001790_abnormal_immune_system | 1.99491862 |
20 | MP0005387_immune_system_phenotype | 1.99491862 |
21 | MP0004510_myositis | 1.96093161 |
22 | MP0005464_abnormal_platelet_physiology | 1.91155878 |
23 | MP0002419_abnormal_innate_immunity | 1.88788712 |
24 | MP0003828_pulmonary_edema | 1.87666942 |
25 | MP0010368_abnormal_lymphatic_system | 1.82766826 |
26 | MP0005025_abnormal_response_to | 1.80469539 |
27 | MP0003172_abnormal_lysosome_physiology | 1.73607635 |
28 | MP0005000_abnormal_immune_tolerance | 1.72622168 |
29 | MP0003300_gastrointestinal_ulcer | 1.72368332 |
30 | MP0001800_abnormal_humoral_immune | 1.70673385 |
31 | MP0009764_decreased_sensitivity_to | 1.69795963 |
32 | MP0000609_abnormal_liver_physiology | 1.64919587 |
33 | MP0006082_CNS_inflammation | 1.64357324 |
34 | MP0003705_abnormal_hypodermis_morpholog | 1.62571785 |
35 | MP0001348_abnormal_lacrimal_gland | 1.60804320 |
36 | MP0002452_abnormal_antigen_presenting | 1.59963140 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.57365685 |
38 | MP0005671_abnormal_response_to | 1.55202769 |
39 | MP0004947_skin_inflammation | 1.55180395 |
40 | MP0003656_abnormal_erythrocyte_physiolo | 1.53340782 |
41 | MP0002723_abnormal_immune_serum | 1.49087949 |
42 | MP0008469_abnormal_protein_level | 1.48103565 |
43 | MP0002933_joint_inflammation | 1.47865946 |
44 | MP0008260_abnormal_autophagy | 1.45374218 |
45 | MP0000858_altered_metastatic_potential | 1.45321384 |
46 | MP0003806_abnormal_nucleotide_metabolis | 1.45012183 |
47 | MP0001533_abnormal_skeleton_physiology | 1.44338941 |
48 | MP0002998_abnormal_bone_remodeling | 1.36041591 |
49 | MP0003195_calcinosis | 1.35091386 |
50 | MP0008004_abnormal_stomach_pH | 1.35010079 |
51 | MP0005319_abnormal_enzyme/_coenzyme | 1.34269885 |
52 | MP0002166_altered_tumor_susceptibility | 1.33745320 |
53 | MP0002254_reproductive_system_inflammat | 1.33145588 |
54 | MP0001845_abnormal_inflammatory_respons | 1.32491057 |
55 | MP0005332_abnormal_amino_acid | 1.32200068 |
56 | MP0002332_abnormal_exercise_endurance | 1.31729950 |
57 | MP0002118_abnormal_lipid_homeostasis | 1.27856600 |
58 | MP0001819_abnormal_immune_cell | 1.27686687 |
59 | MP0001853_heart_inflammation | 1.26796247 |
60 | MP0002420_abnormal_adaptive_immunity | 1.25720971 |
61 | MP0009333_abnormal_splenocyte_physiolog | 1.25585091 |
62 | MP0004233_abnormal_muscle_weight | 1.24448585 |
63 | MP0001851_eye_inflammation | 1.22307791 |
64 | MP0009278_abnormal_bone_marrow | 1.21563213 |
65 | MP0005310_abnormal_salivary_gland | 1.20642950 |
66 | MP0010155_abnormal_intestine_physiology | 1.18176863 |
67 | MP0009763_increased_sensitivity_to | 1.17638420 |
68 | MP0001545_abnormal_hematopoietic_system | 1.14949156 |
69 | MP0005397_hematopoietic_system_phenotyp | 1.14949156 |
70 | MP0005058_abnormal_lysosome_morphology | 1.14053777 |
71 | MP0000604_amyloidosis | 1.13814935 |
72 | MP0001666_abnormal_nutrient_absorption | 1.13743457 |
73 | MP0001879_abnormal_lymphatic_vessel | 1.13020044 |
74 | MP0000343_altered_response_to | 1.12818874 |
75 | MP0003279_aneurysm | 1.12410523 |
76 | MP0005408_hypopigmentation | 1.11393597 |
77 | MP0002405_respiratory_system_inflammati | 1.09046390 |
78 | MP0004782_abnormal_surfactant_physiolog | 1.08462542 |
79 | MP0005167_abnormal_blood-brain_barrier | 1.08371230 |
80 | MP0002006_tumorigenesis | 1.07611145 |
81 | MP0004019_abnormal_vitamin_homeostasis | 1.05766131 |
82 | MP0000716_abnormal_immune_system | 1.05740911 |
83 | MP0000689_abnormal_spleen_morphology | 1.05473457 |
84 | MP0000598_abnormal_liver_morphology | 1.04726069 |
85 | MP0005023_abnormal_wound_healing | 1.04684648 |
86 | MP0005076_abnormal_cell_differentiation | 1.04384534 |
87 | MP0004036_abnormal_muscle_relaxation | 1.03594025 |
88 | MP0002398_abnormal_bone_marrow | 1.01923995 |
89 | MP0003566_abnormal_cell_adhesion | 1.01622635 |
90 | MP0004883_abnormal_blood_vessel | 1.00624851 |
91 | MP0003075_altered_response_to | 0.99884114 |
92 | MP0003690_abnormal_glial_cell | 0.97526353 |
93 | MP0004858_abnormal_nervous_system | 0.96180949 |
94 | MP0003448_altered_tumor_morphology | 0.95678728 |
95 | MP0004381_abnormal_hair_follicle | 0.95532718 |
96 | MP0005165_increased_susceptibility_to | 0.95251935 |
97 | MP0000249_abnormal_blood_vessel | 0.94606401 |
98 | MP0004130_abnormal_muscle_cell | 0.94190166 |
99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93185012 |
100 | MP0000751_myopathy | 0.92868638 |
101 | MP0005166_decreased_susceptibility_to | 0.92486576 |
102 | MP0003763_abnormal_thymus_physiology | 0.91497823 |
103 | MP0002722_abnormal_immune_system | 0.90718179 |
104 | MP0003045_fibrosis | 0.89632131 |
105 | MP0000767_abnormal_smooth_muscle | 0.89389355 |
106 | MP0004185_abnormal_adipocyte_glucose | 0.89235553 |
107 | MP0004084_abnormal_cardiac_muscle | 0.89121969 |
108 | MP0005075_abnormal_melanosome_morpholog | 0.88935876 |
109 | MP0009643_abnormal_urine_homeostasis | 0.88683214 |
110 | MP0005666_abnormal_adipose_tissue | 0.88647238 |
111 | MP0003868_abnormal_feces_composition | 0.86938166 |
112 | MP0005670_abnormal_white_adipose | 0.86002247 |
113 | MP0002429_abnormal_blood_cell | 0.85460666 |
114 | MP0003329_amyloid_beta_deposits | 0.83888084 |
115 | MP0004808_abnormal_hematopoietic_stem | 0.83186107 |
116 | MP0005164_abnormal_response_to | 0.82506685 |
117 | MP0000465_gastrointestinal_hemorrhage | 0.82071371 |
118 | MP0009697_abnormal_copulation | 0.81705307 |
119 | MP0001958_emphysema | 0.81497389 |
120 | MP0004484_altered_response_of | 0.81451794 |
121 | MP0005390_skeleton_phenotype | 0.80745226 |
122 | MP0002136_abnormal_kidney_physiology | 0.80138361 |
123 | MP0002877_abnormal_melanocyte_morpholog | 0.77702303 |
124 | MP0003453_abnormal_keratinocyte_physiol | 0.77171926 |
125 | MP0008438_abnormal_cutaneous_collagen | 0.76521724 |
126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76332998 |
127 | MP0001873_stomach_inflammation | 0.73573158 |
128 | MP0003091_abnormal_cell_migration | 0.72858444 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 5.26224309 |
2 | Complement deficiency (HP:0004431) | 4.16588181 |
3 | Joint hemorrhage (HP:0005261) | 4.08731183 |
4 | Xanthomatosis (HP:0000991) | 4.01116731 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92047198 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 3.88331314 |
7 | Intrahepatic cholestasis (HP:0001406) | 3.87927225 |
8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.70381399 |
9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.68940912 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.68724006 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.68724006 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.68724006 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 3.63183661 |
14 | Myocardial infarction (HP:0001658) | 3.62413838 |
15 | Hyperlipoproteinemia (HP:0010980) | 3.43927693 |
16 | Gingival bleeding (HP:0000225) | 3.41041957 |
17 | Mitral stenosis (HP:0001718) | 3.30846632 |
18 | Systemic lupus erythematosus (HP:0002725) | 3.23588261 |
19 | Abnormality of complement system (HP:0005339) | 3.22953183 |
20 | Eczematoid dermatitis (HP:0000976) | 3.16809641 |
21 | Dysostosis multiplex (HP:0000943) | 3.09523202 |
22 | Glomerulonephritis (HP:0000099) | 3.04680695 |
23 | Mediastinal lymphadenopathy (HP:0100721) | 2.99392358 |
24 | Asymmetric septal hypertrophy (HP:0001670) | 2.97985377 |
25 | Interstitial pulmonary disease (HP:0006530) | 2.96750644 |
26 | Spontaneous hematomas (HP:0007420) | 2.96470558 |
27 | Esophageal varix (HP:0002040) | 2.94900684 |
28 | Epidermoid cyst (HP:0200040) | 2.91351834 |
29 | Autoimmune thrombocytopenia (HP:0001973) | 2.91006272 |
30 | Hypobetalipoproteinemia (HP:0003563) | 2.90457845 |
31 | Menorrhagia (HP:0000132) | 2.89240802 |
32 | Recurrent bacterial skin infections (HP:0005406) | 2.88430908 |
33 | Loss of speech (HP:0002371) | 2.74810835 |
34 | Recurrent abscess formation (HP:0002722) | 2.71051608 |
35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.69356680 |
36 | Mucopolysacchariduria (HP:0008155) | 2.69356680 |
37 | Nephritis (HP:0000123) | 2.69032552 |
38 | Vascular calcification (HP:0004934) | 2.68730916 |
39 | Epistaxis (HP:0000421) | 2.67783262 |
40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.66453118 |
41 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.66453118 |
42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.66453118 |
43 | Retrobulbar optic neuritis (HP:0100654) | 2.64550534 |
44 | Optic neuritis (HP:0100653) | 2.64550534 |
45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.62011012 |
46 | Hypoalphalipoproteinemia (HP:0003233) | 2.61418045 |
47 | Hypercholesterolemia (HP:0003124) | 2.60761286 |
48 | Polycythemia (HP:0001901) | 2.56316236 |
49 | Hypolipoproteinemia (HP:0010981) | 2.51962935 |
50 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.51496872 |
51 | Pulmonary embolism (HP:0002204) | 2.50906407 |
52 | Cardiovascular calcification (HP:0011915) | 2.50530030 |
53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.50261837 |
54 | Thrombophlebitis (HP:0004418) | 2.49333707 |
55 | Amyloidosis (HP:0011034) | 2.46935822 |
56 | Vasculitis (HP:0002633) | 2.44409893 |
57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.42186526 |
58 | Myositis (HP:0100614) | 2.41350015 |
59 | Prolonged bleeding time (HP:0003010) | 2.37341767 |
60 | Joint swelling (HP:0001386) | 2.36590048 |
61 | Chronic otitis media (HP:0000389) | 2.35578081 |
62 | T lymphocytopenia (HP:0005403) | 2.33142758 |
63 | Peritonitis (HP:0002586) | 2.32175821 |
64 | Distal lower limb muscle weakness (HP:0009053) | 2.32106606 |
65 | Periodontitis (HP:0000704) | 2.31848350 |
66 | Spondylolisthesis (HP:0003302) | 2.31466056 |
67 | Hepatocellular carcinoma (HP:0001402) | 2.29956926 |
68 | Spontaneous abortion (HP:0005268) | 2.29669825 |
69 | Vacuolated lymphocytes (HP:0001922) | 2.28117560 |
70 | Orchitis (HP:0100796) | 2.28053249 |
71 | Abnormal platelet volume (HP:0011876) | 2.26500775 |
72 | Abnormal platelet function (HP:0011869) | 2.25328564 |
73 | Impaired platelet aggregation (HP:0003540) | 2.25328564 |
74 | Gastrointestinal infarctions (HP:0005244) | 2.23426313 |
75 | Vertebral compression fractures (HP:0002953) | 2.22915743 |
76 | Abnormality of the peritoneum (HP:0002585) | 2.22480315 |
77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21821284 |
78 | Cellulitis (HP:0100658) | 2.21563699 |
79 | Recurrent skin infections (HP:0001581) | 2.21077594 |
80 | Purpura (HP:0000979) | 2.20426202 |
81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19879432 |
82 | Abnormality of iron homeostasis (HP:0011031) | 2.19339401 |
83 | Hematochezia (HP:0002573) | 2.18695229 |
84 | Arterial thrombosis (HP:0004420) | 2.18651986 |
85 | Axonal loss (HP:0003447) | 2.18591205 |
86 | Recurrent fungal infections (HP:0002841) | 2.18357360 |
87 | Recurrent viral infections (HP:0004429) | 2.16012226 |
88 | Pustule (HP:0200039) | 2.15945744 |
89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.15314197 |
90 | Hemorrhage of the eye (HP:0011885) | 2.14915103 |
91 | Increased serum ferritin (HP:0003281) | 2.14085777 |
92 | Exercise-induced myalgia (HP:0003738) | 2.13943732 |
93 | Increased mean platelet volume (HP:0011877) | 2.10646084 |
94 | Hyporeflexia of lower limbs (HP:0002600) | 2.10603242 |
95 | Abnormality of macrophages (HP:0004311) | 2.08252495 |
96 | Increased connective tissue (HP:0009025) | 2.08007993 |
97 | Hyperammonemia (HP:0001987) | 2.07194301 |
98 | Abnormality of the nasal mucosa (HP:0000433) | 2.06355988 |
99 | Fat malabsorption (HP:0002630) | 2.05676322 |
100 | Abnormality of T cell number (HP:0011839) | 2.05639640 |
101 | Meningitis (HP:0001287) | 2.05053687 |
102 | Microcytic anemia (HP:0001935) | 2.03058703 |
103 | Osteolytic defects of the hand bones (HP:0009699) | 2.00804823 |
104 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00804823 |
105 | Stomatitis (HP:0010280) | 1.99507281 |
106 | Hypoglycemic coma (HP:0001325) | 1.98539090 |
107 | Hyperbilirubinemia (HP:0002904) | 1.95569392 |
108 | Chest pain (HP:0100749) | 1.95524642 |
109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95487394 |
110 | Obstructive lung disease (HP:0006536) | 1.95018480 |
111 | Chronic obstructive pulmonary disease (HP:0006510) | 1.95018480 |
112 | Pulmonary infiltrates (HP:0002113) | 1.94638592 |
113 | Increased cerebral lipofuscin (HP:0011813) | 1.92884488 |
114 | Urticaria (HP:0001025) | 1.89700930 |
115 | Neurofibrillary tangles (HP:0002185) | 1.89362073 |
116 | Skin nodule (HP:0200036) | 1.89170050 |
117 | Abnormality of purine metabolism (HP:0004352) | 1.88917822 |
118 | Acanthocytosis (HP:0001927) | 1.88721734 |
119 | Aneurysm (HP:0002617) | 1.88567653 |
120 | Cerebral inclusion bodies (HP:0100314) | 1.88245183 |
121 | Ketosis (HP:0001946) | 1.87425286 |
122 | Late onset (HP:0003584) | 1.86843146 |
123 | Hemoptysis (HP:0002105) | 1.86346225 |
124 | Tetraparesis (HP:0002273) | 1.85055596 |
125 | Subacute progressive viral hepatitis (HP:0006572) | 1.84274622 |
126 | Poikilocytosis (HP:0004447) | 1.83418155 |
127 | Gingivitis (HP:0000230) | 1.83330229 |
128 | Slow saccadic eye movements (HP:0000514) | 1.82277727 |
129 | Colitis (HP:0002583) | 1.81515372 |
130 | Abnormality of methionine metabolism (HP:0010901) | 1.80391942 |
131 | Abnormality of nucleobase metabolism (HP:0010932) | 1.79456342 |
132 | Protrusio acetabuli (HP:0003179) | 1.79252376 |
133 | Inflammation of the large intestine (HP:0002037) | 1.79123905 |
134 | Cerebral aneurysm (HP:0004944) | 1.77494687 |
135 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77052894 |
136 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77052894 |
137 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.76666535 |
138 | Distal lower limb amyotrophy (HP:0008944) | 1.76347309 |
139 | Thoracic kyphosis (HP:0002942) | 1.76116879 |
140 | Autoimmune hemolytic anemia (HP:0001890) | 1.75934097 |
141 | Spinal cord lesions (HP:0100561) | 1.75732201 |
142 | Gastrointestinal inflammation (HP:0004386) | 1.75375252 |
143 | Neonatal hypoglycemia (HP:0001998) | 1.75081343 |
144 | Cervical subluxation (HP:0003308) | 1.74838217 |
145 | Thin bony cortex (HP:0002753) | 1.73894479 |
146 | Keratoconjunctivitis sicca (HP:0001097) | 1.72333007 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.95730187 |
2 | MAP4K1 | 3.14026146 |
3 | FGFR4 | 2.79496574 |
4 | PRPF4B | 2.77614308 |
5 | TRIB3 | 2.72441833 |
6 | MAP3K14 | 2.67558021 |
7 | TYK2 | 2.66779307 |
8 | TBK1 | 2.49456383 |
9 | TGFBR2 | 2.38860573 |
10 | SIK1 | 2.37347183 |
11 | JAK3 | 2.16248922 |
12 | TAOK3 | 2.09783111 |
13 | PKN2 | 2.05890229 |
14 | JAK1 | 1.98947357 |
15 | KIT | 1.90926143 |
16 | AKT3 | 1.82862026 |
17 | IRAK3 | 1.81137596 |
18 | IKBKE | 1.79218327 |
19 | TIE1 | 1.77579228 |
20 | BLK | 1.74487022 |
21 | MAP3K10 | 1.68457455 |
22 | EPHB1 | 1.61720552 |
23 | ZAP70 | 1.57081147 |
24 | NEK9 | 1.50285520 |
25 | CSK | 1.48709980 |
26 | ICK | 1.43759259 |
27 | IKBKB | 1.41816817 |
28 | FGFR3 | 1.41762783 |
29 | EPHA2 | 1.40504488 |
30 | CAMK1D | 1.39245909 |
31 | PTK6 | 1.38527470 |
32 | JAK2 | 1.37192931 |
33 | TXK | 1.36674796 |
34 | LMTK2 | 1.35481101 |
35 | HCK | 1.31585442 |
36 | PRKD3 | 1.25953888 |
37 | LRRK2 | 1.25176463 |
38 | BCKDK | 1.25062199 |
39 | CHUK | 1.24603877 |
40 | CDK6 | 1.24565322 |
41 | IRAK4 | 1.24531054 |
42 | KDR | 1.24201800 |
43 | MAP2K3 | 1.24042589 |
44 | EPHA3 | 1.21580507 |
45 | TNK2 | 1.21421853 |
46 | MAP3K13 | 1.19472930 |
47 | CDC42BPA | 1.19449222 |
48 | RIPK1 | 1.19175538 |
49 | STK10 | 1.18548560 |
50 | SYK | 1.18181322 |
51 | TAOK2 | 1.18132796 |
52 | BMX | 1.16810197 |
53 | TAOK1 | 1.15980268 |
54 | PRKD2 | 1.13549639 |
55 | CSF1R | 1.11710472 |
56 | BTK | 1.09797728 |
57 | TTN | 1.08301075 |
58 | MAP3K7 | 1.02338729 |
59 | PIM1 | 0.96819778 |
60 | MST1R | 0.96172745 |
61 | FGR | 0.95871053 |
62 | CAMK1G | 0.95497267 |
63 | GRK6 | 0.92654574 |
64 | GRK7 | 0.90332832 |
65 | RIPK4 | 0.87406060 |
66 | MAPK4 | 0.86208915 |
67 | PIK3CG | 0.85463050 |
68 | CAMKK2 | 0.83170541 |
69 | PDPK1 | 0.82384073 |
70 | FLT3 | 0.78159564 |
71 | MARK2 | 0.78122192 |
72 | MAP3K3 | 0.77872786 |
73 | RPS6KA4 | 0.77041558 |
74 | EEF2K | 0.76577820 |
75 | SMG1 | 0.76546998 |
76 | LCK | 0.76350606 |
77 | TGFBR1 | 0.75678558 |
78 | SIK2 | 0.75455124 |
79 | SCYL2 | 0.74207051 |
80 | LYN | 0.73688319 |
81 | TEC | 0.69623391 |
82 | PAK4 | 0.69312690 |
83 | MAPK11 | 0.69278344 |
84 | ITK | 0.68817878 |
85 | NME2 | 0.67806306 |
86 | STK38 | 0.67758782 |
87 | IRAK1 | 0.67562642 |
88 | STK3 | 0.66675166 |
89 | BMPR2 | 0.66305363 |
90 | KSR2 | 0.63630530 |
91 | MAPK7 | 0.63578591 |
92 | ABL2 | 0.63453746 |
93 | NLK | 0.63269756 |
94 | EGFR | 0.62030183 |
95 | ABL1 | 0.61528129 |
96 | PRKAA2 | 0.61105796 |
97 | CDK12 | 0.60756151 |
98 | OBSCN | 0.59958679 |
99 | IRAK2 | 0.59751427 |
100 | HIPK2 | 0.58965760 |
101 | DDR2 | 0.58690744 |
102 | MAP3K6 | 0.58669550 |
103 | DYRK1B | 0.58616887 |
104 | MYLK | 0.58432199 |
105 | MTOR | 0.58216746 |
106 | SGK3 | 0.57589625 |
107 | PDGFRB | 0.57515687 |
108 | PRKG2 | 0.57222874 |
109 | PRKCH | 0.57098689 |
110 | RPS6KC1 | 0.56543784 |
111 | RPS6KL1 | 0.56543784 |
112 | PDGFRA | 0.56275313 |
113 | FER | 0.54981498 |
114 | INSRR | 0.53507479 |
115 | MAP3K11 | 0.52436408 |
116 | FES | 0.52198588 |
117 | RPS6KA2 | 0.51322727 |
118 | PRKCQ | 0.50152082 |
119 | STK4 | 0.49661607 |
120 | TESK2 | 0.49576750 |
121 | MAPK12 | 0.49116360 |
122 | MUSK | 0.48600730 |
123 | PIM2 | 0.47500077 |
124 | MARK3 | 0.47317311 |
125 | MATK | 0.46053948 |
126 | MAP3K1 | 0.45700634 |
127 | YES1 | 0.45330528 |
128 | GSK3A | 0.44171166 |
129 | RET | 0.42353985 |
130 | CDK4 | 0.41971847 |
131 | LATS1 | 0.41709594 |
132 | TRPM7 | 0.41489402 |
133 | CDK9 | 0.38746544 |
134 | ERBB4 | 0.37716900 |
135 | PDK1 | 0.37509268 |
136 | SIK3 | 0.36764929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44266117 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.24196302 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.05742852 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.96477540 |
5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70825735 |
6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.66536374 |
7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.44853904 |
8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.38134690 |
9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.18607752 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14110803 |
11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96528138 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.73184534 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.70118833 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.68286992 |
15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67367654 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.63594883 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.44978162 |
18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44532338 |
19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40357691 |
20 | Malaria_Homo sapiens_hsa05144 | 1.37370267 |
21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.37013625 |
22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36050929 |
23 | Measles_Homo sapiens_hsa05162 | 1.27022709 |
24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24783016 |
25 | ABC transporters_Homo sapiens_hsa02010 | 1.24036977 |
26 | Peroxisome_Homo sapiens_hsa04146 | 1.23226401 |
27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21739659 |
28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.21471298 |
29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.20921526 |
30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19811104 |
31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17145762 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15958641 |
33 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.15561636 |
34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12070334 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11933836 |
36 | Pertussis_Homo sapiens_hsa05133 | 1.11332112 |
37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09645729 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.07834177 |
39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07139049 |
40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05967765 |
41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04634872 |
42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04571993 |
43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02195054 |
44 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01701838 |
45 | Bile secretion_Homo sapiens_hsa04976 | 1.00484270 |
46 | Tuberculosis_Homo sapiens_hsa05152 | 0.99053300 |
47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.98493349 |
48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98390519 |
49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.97534905 |
50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.97379938 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96720400 |
52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96015716 |
53 | Lysine degradation_Homo sapiens_hsa00310 | 0.95405263 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93831692 |
55 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92509258 |
56 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90796306 |
57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90321475 |
58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90308838 |
59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89017381 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88523105 |
61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.88201581 |
62 | Legionellosis_Homo sapiens_hsa05134 | 0.87588251 |
63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86831895 |
64 | Influenza A_Homo sapiens_hsa05164 | 0.84585931 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.84096443 |
66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84094428 |
67 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84040029 |
68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82226808 |
69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81753393 |
70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79990369 |
71 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79086930 |
72 | Bladder cancer_Homo sapiens_hsa05219 | 0.78095978 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77320057 |
74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75833459 |
75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75461958 |
76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74993358 |
77 | Phagosome_Homo sapiens_hsa04145 | 0.74195721 |
78 | Hepatitis B_Homo sapiens_hsa05161 | 0.73374784 |
79 | Allograft rejection_Homo sapiens_hsa05330 | 0.72600029 |
80 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70994282 |
81 | Amoebiasis_Homo sapiens_hsa05146 | 0.70377428 |
82 | Shigellosis_Homo sapiens_hsa05131 | 0.69889623 |
83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69218591 |
84 | Apoptosis_Homo sapiens_hsa04210 | 0.69086474 |
85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68495244 |
86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66567697 |
87 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66453237 |
88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65924992 |
89 | Hepatitis C_Homo sapiens_hsa05160 | 0.65762604 |
90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.65662821 |
91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65363184 |
92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65212545 |
93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64254288 |
94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63661996 |
95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63640835 |
96 | Focal adhesion_Homo sapiens_hsa04510 | 0.63199922 |
97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62916398 |
98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62787067 |
99 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62697816 |
100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60898244 |
101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60523134 |
102 | Platelet activation_Homo sapiens_hsa04611 | 0.60521717 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60513579 |
104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60444350 |
105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60035319 |
106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59554449 |
107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58935485 |
108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58455589 |
109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57588847 |
110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57034932 |
111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56489485 |
112 | Endocytosis_Homo sapiens_hsa04144 | 0.56283352 |
113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56268033 |
114 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55528507 |
115 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52814742 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.51854425 |
117 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51607706 |
118 | Prostate cancer_Homo sapiens_hsa05215 | 0.50961414 |
119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49981696 |
120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49507183 |
121 | Lysosome_Homo sapiens_hsa04142 | 0.49299834 |
122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49127641 |
123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.48442351 |
124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47799039 |
125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47794261 |
126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47554436 |
127 | Asthma_Homo sapiens_hsa05310 | 0.47225933 |
128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.46611776 |
129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46603852 |
130 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46172731 |
131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46059711 |
132 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.44609467 |
133 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.43397788 |
134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43152373 |
135 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41260345 |
136 | Salmonella infection_Homo sapiens_hsa05132 | 0.41091702 |
137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40545476 |
138 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40198625 |
139 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39095272 |
140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37365711 |